Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels James S. YehAmeet SarpatwariAaron S. Kesselheim Current Opinion 21 March 2016 Pages: 709 - 714
Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease Alexander C. FanaroffMatthew T. Roe Review Article 30 March 2016 Pages: 715 - 727
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease Rolf TeschkeGaby Danan Review Article 18 April 2016 Pages: 729 - 744
Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis Chee Fu YungChia Yin ChongKoh Cheng Thoon Short Communication 11 April 2016 Pages: 745 - 748
Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study Elizabeth X. ZhengSimona RossiVictor J. Navarro Original Research Article 17 May 2016 Pages: 749 - 754
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis Megan E. B. ClowseSteven R. FeldmanAmy Marren Original Research Article Open access 09 June 2016 Pages: 755 - 762
Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment Mulugeta RussomDawit TesfaiGelila Abrham Original Research Article 20 May 2016 Pages: 763 - 768
The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands Leàn RolfesFlorence van HunselEugène van Puijenbroek Original Research Article Open access 04 May 2016 Pages: 769 - 776
Is Earlier Signal Detection Always Better? Alan M. HochbergStella Stergiopoulos Letter to the Editor 11 April 2016 Pages: 777 - 778